Hematocrit and risk of venous thromboembolism in a general population. The Tromsø study

Haematologica

Volumn 95, Issue 2, 2010, Pages 270-275

  Brækkan, Sigrid Kufaas ^a   Mathiesen, Ellisiv B ^a   Njølstad, Inger ^a   Wilsgaard, Tom ^a   Hansen, John Bjarne ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Arterial and venous thrombosis; Hematocrit; Population range

Indexed keywords

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; ERYTHROCYTE COUNT; FEMALE; FOLLOW UP; HEMATOCRIT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR VOLUME; RISK ASSESSMENT; SMOKING; VENOUS THROMBOEMBOLISM;

ADULT; ERYTHROCYTE COUNT; ERYTHROCYTE INDICES; FEMALE; FOLLOW-UP STUDIES; HEMATOCRIT; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 76549088896     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2009.008417     Document Type: Article

References (29)

1. Heit JA. Venous thromboembolism: disease burden, outcomes and risk factors. J Thromb Haemost 2005; 3(8):1611-7.
2. Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet. 1999; 353(9159): 1167-73.
3. White RH. The epidemiology of venous thromboembolism. Circulation. 2003; 107(23 Suppl 1):I4-8.
4. Virchow R. Thrombose und Embolie (1846-1856). Leipzig, Germany: Verlag von Johann Ambrosius Barth, 1910.
5. Wells RE Jr, Merrill EW. Influence of flow properties of blood upon viscosity-hematocrit relationships. J Clin Invest. 1962;41: 1591-8.
6. Guyton AC, Richardson TQ. Effect of hematocrit on venous return. Circ Res. 1961;9:157-64.
7. Hellem AJ, Borchgrevink CF, Ames SB. The role of red cells in haemostasis: the relation between haematocrit, bleeding time and platelet adhesiveness. Br J Haematol. 1961; 7:42-50.
8. Polycythemia vera: the natural history of 1213 patients followed for 20 years. Gruppo Italiano Studio Policitemia. Ann Intern Med. 1995; 123(9):656-64.
9. Boneu B. Laboratory investigations and prediction of thrombotic risk in polycythemia vera. Nouv Rev Fr Hematol. 1994; 36(2):183-5.
10. Pearson TC, Wetherley-Mein G. Vascular occlusive episodes and venous haematocrit in primary proliferative polycythaemia. Lancet. 1978;2(8102):1219- 22.
11. Schafer AI. Bleeding and thrombosis in the myeloproliferative disorders. Blood. 1984; 64(1):1-12.
12. Wehmeier A, Daum I, Jamin H, Schneider W. Incidence and clinical risk factors for bleeding and thrombotic complications in myeloproliferative disorders. A retrospective analysis of 260 patients. Ann Hematol. 1991;63(2):101-6.
13. Gagnon DR, Zhang TJ, Brand FN, Kannel WB. Hematocrit and the risk of cardiovascular disease - the Framingham study: a 34-year follow-up. Am Heart J. 1994;127(3):674-82.
14. Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Polak JF, Folsom AR. Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch Intern Med. 2002;162(10):1182-9.
15. Vayá A, Mira Y, Martínez M, Villa P, Ferrando F, Estellés A, et al. Biological risk factors for deep vein trombosis. Clin Hemorheol Microcirc. 2002;26(1):41-53.
16. Ageno W, Becattini C, Brighton T, Selby R, Kamphuisen PW. Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation. 2008;117(1):93-102.
17. Prandoni P, Bilora F, Marchiori A, Bernardi E, Petrobelli F, Lensing AW, et al. An association between atherosclerosis and venous thrombosis. N Engl J Med. 2003;348(15): 1435-41.
18. Sorensen HT, Horvath-Puho E, Pedersen L, Baron JA, Prandoni P. Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study. Lancet. 2007; 370(9601):1773-9.
19. Danesh J, Collins R, Peto R, Lowe GD. Haematocrit, viscosity, erythrocyte sedimentation rate: meta-analyses of prospective studies of coronary heart disease. Eur Heart J. 2000; 21(7):515-20.
20. Ho CH. The hemostatic effect of adequate red cell transfusion in patients with anemia and thrombocytopenia. Transfusion. 1996; 36(3):290.
21. Allan A, Williams JT, Bolton JP, Le Quesne LP. The use of graduated compression stockings in the prevention of postoperative deep vein thrombosis. Br J Surg. 1983; 70(3):172-4.
22. Roderick P, Ferris G, Wilson K, Halls H, Jackson D, Collins R, et al. Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis. Health Technol Assess. 2005;9(49):1-78.
23. Turitto VT, Weiss HJ. Red blood cells: their dual role in thrombus formation. Science. 1980;207(4430):541-3.
24. Dintenfass L. Viscosity and clotting of blood in venous thrombosis and coronary occlusions. Circ Res. 1964;14:1-16.
25. Horne MK 3rd, Cullinane AM, Merryman PK, Hoddeson EK. The effect of red blood cells on thrombin generation. Br J Haematol. 2006; 133(4):403-8.
26. Gaarder A, Jonsen J, Laland S, Hellem A, Owren PA. Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets. Nature. 1961;192: 531-2.
27. Santos MT, Valles J, Marcus AJ, Safier LB, Broekman MJ, Islam N, et al. Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. A new approach to platelet activation and recruitment. J Clin Invest. 1991; 87(2):571-80.
28. Valles J, Santos MT, Aznar J, Marcus AJ, Martinez-Sales V, Portoles M, et al. Erythrocytes metabolically enhance collagen-induced platelet responsiveness via increased thromboxane production, adenosine diphosphate release, and recruitment. Blood. 1991;78(1):154-62.
29. Zwaal RF, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood. 1997; 89(4):1121-32.